Radiofrequency catheter ablation of atrial flutter induces the release of platelet and leukocyte-derived procoagulant microparticles and a prothrombotic state

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 2, 2009, Pages 193-200

  Jesel, Laurence ^a   Morel, Olivier ^a,b,c   Pynn, Sophie ^a   Radulescu, Bogdan ^a   Grunebaum, Lelia ^c   Freyssinet, Jean Marie ^b   Ohlmann, Patrick ^a   Bareiss, Pierrre ^a   Toti, Florence ^b,d   Chauvin, Michel ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Apoptosis; Coagulation; Endothelial activation; Inflammation; Leukocyte

Indexed keywords

BLOOD CLOTTING FACTOR 10A; D DIMER; VON WILLEBRAND FACTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FIBRINOLYSIS; HEART ATRIUM FLUTTER; HUMAN; HUMAN CELL; LEUKOCYTE MICROPARTICLE; MALE; THROMBOCYTE;

AGED; ATRIAL FLUTTER; CATHETER ABLATION; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET ACTIVATION; THROMBOSIS;

EID: 58849091782     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.02202.x     Document Type: Article

References (27)

1. Brueckmann M, Wolpert C, Bertsch T, Sueselbeck T, Liebetrau C, Kaden JJ, Huhle G, et al. Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004 15 : 686 691.
2. Oswald H, Gardiwal A, Lissel C, Yu H, Klein G. Difference in humoral biomarkers for myocardial injury and inflammation in radiofrequency ablation versus cryoablation. Pacing Clin Electrophysiol 2007 30 : 885 890.
3. Hochholzer W, Schlittenhardt D, Arentz T, Stockinger J, Weber R, Burkle G, Kalusche D, et al. Platelet activation and myocardial necrosis in patients undergoing radiofrequency and cryoablation of isthmus-dependent atrial flutter. Europace 2007 9 : 490 495.
4. Bouchama A, Kunzelman C, Dehbi M, Kwaasi A, Eldali A, Zobairi F, Freyssinet JM, et al. Recombinant activated protein C attenuates endothelial injury and inhibits procoagulant microparticles release in baboon heatstroke. Arterioscler Thromb Vasc Biol 2008 28 : 1318 1325.
5. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003 59 : 277 287.
6. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: Disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006 26 : 2594 2604.
7. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000 101 : 841 843.
8. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity. Circulation 1999 99 : 348 353.
9. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005 45 : 1622 1630.
10. Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet MP, Zupan M, et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004 2 : 1118 1126.
11. Chironi G, Simon A, Hugel B, Del-Pino M, Gariepy J, Freyssinet JM, Tedgui A. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 2006 26 : 2775 2780.
12. Leroyer AS, Isobe H, Lesèche G, Castier Y, Wassef M, Mallat Z, Binder BR, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007 49 : 772 777.
13. Ederhy S, Di Angelantonio E, Mallat Z, Hugel B, Janower S, Meuleman C, Boccara F, et al. Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation. Am J Cardiol 2007 100 : 989 994.
14. Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993 72 : 295 304.
15. Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating endothelial microparticles in acute ischemic stroke: A link to severity, lesion volume and outcome. J Thromb Haemost 2006 4 : 1296 1302.
16. Periard D, Boulanger CM, Eyer S, Amabile N, Pugin N, Gerscheimer C, Hayoz D. Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke 2007 38 : 1636 1638.
17. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, Freyssinet JM. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997 99 : 1546 1554.
18. Hugel B, Zobairi F, Freyssinet JM. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004 2 : 1846 1847.
19. van Oeveren W, Crijns HJ, Korteling BJ, Wegereef EW, Haan J, Tigchelaar I, Hoekstra A. Blood damage, platelet and clotting activation during application of radiofrequency or cryoablation catheters: A comparative in vitro study. J Med Eng Technol 1999 23 : 20 25.
20. Tse HF, Kwong YL, Lau CP. Transvenous cryoablation reduces platelet activation during pulmonary vein ablation compared with radiofrequency energy in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2005 16 : 1064 1070.
21. Morel O, Hugel B, Jesel L, Lanza F, Douchet MP, Zupan M, Chauvin M, et al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004 91 : 345 353.
22. Reininger AJ, Heijnen HF, Schumann H, Specht HM, Schramm W, Ruggeri ZM. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006 107 : 3537 3545.
23. Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996 88 : 3456 3464.
24. Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995 21 : 217 231 discussion 231a.
25. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005 25 : 1512 1518.
26. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003 197 : 1585 1598.
27. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, et al. Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci U S A 1999 96 : 2311 2315.